カテゴリ： MarketLine, オーストラリア, 企業調査

Macquarie Group Ltd：企業の戦略・SWOT・財務情報

◆英語タイトル：Macquarie Group Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C6252
◆発行会社（調査会社）：MarketLine
◆発行日：2018年10月
◆ページ数：74
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：オーストラリア
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Macquarie Group Ltd – Strategy, SWOT and Corporate Finance Report
Summary

Macquarie Group Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Macquarie Group Ltd (Macquarie) is a provider of diverse financial solutions such as banking, finance and asset management, advisory, and risk and capital solutions across various asset classes. It acts as an investment intermediary for corporate, institutions, government and retail clients. The group offers corporate and structured finance; mortgages and leasing; fund management products; investment management; underwriting; facilitation; broking; real estate development; principal investments; and trading solutions in equities, fixed income securities, commodities, currency and derivatives. The group majorly serves sectors such as resources and commodities, financial institutions, green energy, conventional energy, infrastructure and real estate in Asia-Pacific, the Americas, the Middle-East, Europe, and Africa. Macquarie is headquartered in Sydney, Australia.

Scope

- Detailed information on Macquarie Group Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Macquarie Group Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Macquarie Group Ltd including a breakdown and examination of key business segments
- Intelligence on Macquarie Group Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Macquarie Group Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Macquarie Group Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Macquarie Group Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Macquarie Group Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Macquarie Group Ltd: Company Overview 9
Macquarie Group Ltd: Overview and Key Facts 9
Macquarie Group Ltd: Overview 9
Macquarie Group Ltd: Key Facts 9
Macquarie Group Ltd: Key Employees 10
Macquarie Group Ltd: Key Employee Biographies 14
Macquarie Group Ltd: Major Products and Services 21
Macquarie Group Ltd: Company History 22
Macquarie Group Ltd: Management Statement 29
Macquarie Group Ltd: Locations and Subsidiaries 34
Macquarie Group Ltd: Key Competitors 39
Macquarie Group Ltd: Company Analysis 40
Macquarie Group Ltd: Business Description 40
Macquarie Group Ltd: SWOT Analysis 47
Macquarie Group Ltd: SWOT Overview 47
Macquarie Group Ltd: Strengths 47
Macquarie Group Ltd: Weaknesses 48
Macquarie Group Ltd: Opportunities 48
Macquarie Group Ltd: Threats 49
Macquarie Group Ltd: Corporate Financial Deals Activity 50
Macquarie Group Ltd: Financial Deals Overview 50
Macquarie Group Ltd: Targets and Partners 52
Macquarie Group Ltd: Top Deals 2014 – 2018YTD* 55
Macquarie Group Ltd: Advisors 56
Macquarie Group Ltd: Top Legal Advisors 56
Macquarie Group Ltd: Top Financial Advisors 56
Macquarie Group Ltd: Mergers and Acquisitions 58
Macquarie Group Ltd: Corporate Venturing 59
Macquarie Group Ltd: Capital Raising 60
Macquarie Group Ltd: Partnership 61
Macquarie Group Ltd: Divestments 62
Macquarie Group Ltd: Recent Developments 63
Macquarie Group Ltd: News and Events Summary 63
Macquarie Group Ltd: Business Expansion 66
Macquarie Group Ltd: Business Reorganization 67
Macquarie Group Ltd: Contracts 67
Macquarie Group Ltd: Corporate Governance 68
Macquarie Group Ltd: Financial Deals 69
Macquarie Group Ltd: Financial Performance 69
Macquarie Group Ltd: Regulatory and Legal Events 70
Macquarie Group Ltd: Strategy and Operations 70
Appendix 72
Contact Us 72
Methodology 72
About MarketLine 73

List of Tables
Table 1: Macquarie Group Ltd: Key Facts
Table 2: Macquarie Group Ltd: Key Employees
Table 3: Macquarie Group Ltd: Company History
Table 4: Macquarie Group Ltd: Locations and Subsidiaries
Table 5: Macquarie Group Ltd: Key Competitors
Table 6: Macquarie Group Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Macquarie Group Ltd: M&A Activity by Geography (TTM*)
Table 8: Macquarie Group Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 9: Macquarie Group Ltd: M&A Average Deal Size - Value (US$m)
Table 10: Macquarie Group Ltd: Targets and Partners
Table 11: Macquarie Group Ltd: Top Deals 2014 - 2018YTD*
Table 12: Macquarie Group Ltd: Legal Advisor Ranking by Value (US$m)
Table 13: Macquarie Group Ltd: Financial Advisor Ranking by Value (US$m)
Table 14: Macquarie Group Ltd: M&A Volume and Value Trend (2014 - YTD*2018)
Table 15: Macquarie Group Ltd: M&A Activity by Geography (2014 - YTD*2018)
Table 16: Macquarie Group Ltd: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 17: Macquarie Group Ltd: Corporate Venturing by Geography (2014 - YTD*2018)
Table 18: Macquarie Group Ltd: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 19: Macquarie Group Ltd: Capital Raising by Deal Type (2014 - YTD*2018)
Table 20: Macquarie Group Ltd: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 21: Macquarie Group Ltd: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 22: Macquarie Group Ltd: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 23: Macquarie Group Ltd: Divestments by Geography (2014 - YTD*2018)
Table 24: Macquarie Group Ltd: News and Events Summary
Table 25: Macquarie Group Ltd: Business Expansion
Table 26: Macquarie Group Ltd: Business Reorganization
Table 27: Macquarie Group Ltd: Contracts
Table 28: Macquarie Group Ltd: Corporate Governance
Table 29: Macquarie Group Ltd: Financial Deals
Table 30: Macquarie Group Ltd: Financial Performance
Table 31: Macquarie Group Ltd: Regulatory and Legal Events
Table 32: Macquarie Group Ltd: Strategy and Operations

List of Figures
Figure 1: Macquarie Group Ltd: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Macquarie Group Ltd: M&A Activity by Geography (TTM*)
Figure 3: Macquarie Group Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Macquarie Group Ltd: M&A Average Deal Size - Value (US$m)
Figure 5: Macquarie Group Ltd: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Macquarie Group Ltd: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Macquarie Group Ltd: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Macquarie Group Ltd: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Macquarie Group Ltd: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 10: Macquarie Group Ltd: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 11: Macquarie Group Ltd: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 12: Macquarie Group Ltd: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 13: Macquarie Group Ltd: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 14: Macquarie Group Ltd: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Macquarie Group Ltd：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • The Emirates Group：企業の戦略・SWOT・財務情報
    The Emirates Group - Strategy, SWOT and Corporate Finance Report Summary The Emirates Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • MedMira Inc (MIR)：企業の財務・戦略的SWOT分析
    Summary MedMira Inc (MedMira) is a developer, manufacturer and marketer of rapid diagnostics and technology platforms. The company offers products in the areas of HIV, H. pylori, multiplex, syphilis, miriad rvf toolkit, and tissue and eye banks. MedMira offers Miriad RVF toolkit that facilitates the …
  • Owlstone Medical Ltd：企業の製品パイプライン分析2018
    Summary Owlstone Medical Ltd (Owlstone Medical), formerly Tiger Dawn Ltd, is a diagnostic company. The company develops and commercializes breathalyzers for use in clinical diagnostics and precision medicines. It offers FAIMS Technology for medical applications; Lonestar for disease biomarker detect …
  • Bank of Queensland Limited (BOQ)：企業の財務・戦略的SWOT分析
    Bank of Queensland Limited (BOQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Nordic Nanovector ASA (NANO)：企業の財務・戦略的SWOT分析
    Summary Nordic Nanovector ASA (Nordic Nanovector), formerly Nordic Nanovector AS is a developer and commercializer of antibody radionuclide conjugates for the treatment of hematological cancers. The company’s lead product candidate includes Betalutin, an antibody radionuclide conjugate developed for …
  • The Vanguard Group, Inc.：企業の戦略・SWOT・財務情報
    The Vanguard Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Vanguard Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Saneca Pharmaceuticals as：製薬・医療：M&Aディール及び事業提携情報
    Summary Saneca Pharmaceuticals as (Saneca Pharma) is a contract development and manufacturing organization that develops and manufactures active pharmaceutical ingredients and finished dosage forms. The organization provides products such as API's; 2-aminotridecane adipate, atorvastatin calcium crys …
  • Centers for Disease Control and Prevention-医療機器分野：企業M&A・提携分析
    Summary Centers for Disease Control and Prevention (CDC), a subsidiary of US Department of Health and Human Services is a public health institute that offers health, safety and security threat management solutions. The institute provides health information to fight diseases and support communities f …
  • Citrix Systems Inc (CTXS)：企業の財務・戦略的SWOT分析
    Citrix Systems Inc (CTXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Central National-Gottesman Inc.：企業の戦略・SWOT・財務情報
    Central National-Gottesman Inc. - Strategy, SWOT and Corporate Finance Report Summary Central National-Gottesman Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Lassonde Industries Inc.：企業の戦略・SWOT・財務情報
    Lassonde Industries Inc. - Strategy, SWOT and Corporate Finance Report Summary Lassonde Industries Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • ThromboGenics NV (THR)-製薬・医療分野：企業M&A・提携分析
    Summary ThromboGenics NV (ThromboGenics) is a biotechnology company, which develops and commercializes ophthalmic and cancer medicines. The company’s ocriplasmin, a recombinant derivative of the plasmin protein, is commercialized as Jetrea in the US to treat symptomatic vitreomacular adhesion (VMA) …
  • Polyplus-Transfection SA-製薬・医療分野：企業M&A・提携分析
    Summary Polyplus-Transfection SA (Polyplus) is a biotechnology company that develops and markets solutions for in vivo and in vitro delivery of nucleic acids in research, bioproduction and therapeutics. The company develops its RNA interference such as STICKY SIRNA and SIRNAPLUS for invivo research. …
  • Medicago Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Medicago Inc (Medicago), a subsidiary of Mitsubishi Tanabe Pharma Corp is a clinical-stage biotechnology company that develops and produces vaccines and antibodies. The company concentrates on the discovery and development of novel vaccines and therapeutic proteins for infectious diseases. I …
  • Arno Therapeutics Inc (ARNI)-医療機器分野：企業M&A・提携分析
    Summary Arno Therapeutics Inc (Arno) is a clinical stage biopharmaceutical company that develops products for the treatment of cancer, infectious diseases and other life threatening diseases. The company has exclusive worldwide rights for the development and commercialization of Onapristone (for the …
  • Kopin Corp (KOPN)：企業の財務・戦略的SWOT分析
    Summary Kopin Corp (Kopin) is a technology company that offers wearable technologies and solutions. The company’s products comprise wearable headsets, transmissive liquid crystal displays, batteries, ASIC products, module products, whisper voice chip among others. Kopin technologies and solutions he …
  • Korber AG：戦略・SWOT・企業財務分析
    Korber AG - Strategy, SWOT and Corporate Finance Report Summary Korber AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Ameresco Inc (AMRC)：企業の財務・戦略的SWOT分析
    Ameresco Inc (AMRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Presidio Pharmaceuticals Inc-製薬・医療分野：企業M&A・提携分析
    Summary Presidio Pharmaceuticals Inc (Presidio) is a clinical-stage pharmaceutical company that discovers and develops small-molecule antiviral therapeutics. The company’s products include HCV NS5A, NS5B proteins, lead pan-genotypic HCV NS5A inhibitor, ravidasvir hydrochloride, protease inhibitor, f …
  • Method Products, Inc.：企業の戦略的SWOT分析
    Method Products, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆